1. Home
  2. AADI vs HUIZ Comparison

AADI vs HUIZ Comparison

Compare AADI & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • HUIZ
  • Stock Information
  • Founded
  • AADI 2011
  • HUIZ 2006
  • Country
  • AADI United States
  • HUIZ China
  • Employees
  • AADI N/A
  • HUIZ N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • HUIZ Specialty Insurers
  • Sector
  • AADI Health Care
  • HUIZ Finance
  • Exchange
  • AADI Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • AADI 49.0M
  • HUIZ 41.7M
  • IPO Year
  • AADI N/A
  • HUIZ 2020
  • Fundamental
  • Price
  • AADI $2.11
  • HUIZ $0.72
  • Analyst Decision
  • AADI Hold
  • HUIZ
  • Analyst Count
  • AADI 3
  • HUIZ 0
  • Target Price
  • AADI $1.75
  • HUIZ N/A
  • AVG Volume (30 Days)
  • AADI 114.7K
  • HUIZ 15.0K
  • Earning Date
  • AADI 11-06-2024
  • HUIZ 11-26-2024
  • Dividend Yield
  • AADI N/A
  • HUIZ N/A
  • EPS Growth
  • AADI N/A
  • HUIZ N/A
  • EPS
  • AADI N/A
  • HUIZ 0.06
  • Revenue
  • AADI $25,070,000.00
  • HUIZ $154,359,355.00
  • Revenue This Year
  • AADI $8.10
  • HUIZ N/A
  • Revenue Next Year
  • AADI $8.54
  • HUIZ $10.46
  • P/E Ratio
  • AADI N/A
  • HUIZ $12.20
  • Revenue Growth
  • AADI 7.80
  • HUIZ N/A
  • 52 Week Low
  • AADI $1.21
  • HUIZ $0.43
  • 52 Week High
  • AADI $5.70
  • HUIZ $1.20
  • Technical
  • Relative Strength Index (RSI)
  • AADI 56.23
  • HUIZ 41.40
  • Support Level
  • AADI $1.98
  • HUIZ $0.68
  • Resistance Level
  • AADI $2.40
  • HUIZ $0.85
  • Average True Range (ATR)
  • AADI 0.11
  • HUIZ 0.05
  • MACD
  • AADI 0.01
  • HUIZ -0.01
  • Stochastic Oscillator
  • AADI 36.96
  • HUIZ 23.53

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: